...
首页> 外文期刊>Egyptian Journal of Anaesthesia >Propofol dexmedetomidine versus propofol ketamine for anesthesia of endoscopic retrograde cholangiopancreatography (ERCP) (A randomized comparative study)
【24h】

Propofol dexmedetomidine versus propofol ketamine for anesthesia of endoscopic retrograde cholangiopancreatography (ERCP) (A randomized comparative study)

机译:丙泊酚右美托咪定与丙泊酚氯胺酮用于内镜逆行胰胆管造影术(ERCP)的麻醉(随机比较研究)

获取原文
           

摘要

Objectives The aim of this study was to compare the effects of propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in patients undergoing ERCP regarding hemodynamic changes, propofol requirements and the recovery criteria. Patient and methods Sixty patients aged 20–50 years ASA II or III scheduled for ERCP were enrolled in this study. Patients were randomly allocated into two equal groups: dexmedetomidine/propofol (DP) group and ketamine/propofol (KP) group. DP patients received a loading dose of iv dexmedetomidine 1 μg/kg over 15 min then maintained by a 0.5 μg/kg/h. Group KP patients received a loading dose of iv ketamine 1 mg/kg over15 min then maintained by 0.5 mg/kg/h. Induction of anesthesia was achieved with propofol 2 mg/kg, atracurium 0.5 mg/kg to facilitate endotracheal intubation. Anesthesia was maintained by propofol infusion 5 mg/kg/h, intermittent iv propofol boluses (0.5 mg/kg) were administered if needed. MAP and HR were recorded before loading of study drugs (baseline) and recorded every 5 min after beginning of loading throughout the procedure and just after intubation, then every 15 min for one hour post-operative. Total propofol consumption, recovery time, VAS and postoperative complications (PONV, cognitive dysfunction, and respiratory complications) were recorded. Results The intra-procedural HR and MAP showed high statistical significant differences between both groups throughout the procedure with lower values in DP group ( p 0.01 or 0.001). During the post-procedural period, the HR and MAP were significantly lower in DP group. Propofol consumption was comparable in both groups (268.0 ± 122.3 mg) in DP group versus (304.7 ± 142.0 mg) in KP group. Postprocedural recovery time was significantly shorter in DP group (5.7 ± 1.7 min) compared with (22.2 ± 8.2 min) KP group ( p 0.01). VAS was comparable in the two groups. PONV was 46.67% of KP group, while it was absent in DP group. Post-operative cognitive disorders showed a high statistical significant difference between both groups ( p 0.001) with no cases was reported in DP group. No respiratory complications in both groups. Conclusion Dexmedetomidine–propofol combination as TIVA during ERCP showed better intra-and post-procedural hemodynamic stability, less PONV, less postoperative cognitive dysfunctions and shorter recovery time when compared with ketamine–propofol combination.
机译:目的本研究的目的是比较丙泊酚/右美托咪定和丙泊酚/氯胺酮组合对接受ERCP的患者进行麻醉的血液动力学变化,丙泊酚需求量和恢复标准。患者和方法计划进行ERCP的60例年龄为20-50岁的ASA II或III的患者入选本研究。将患者随机分为两组:右美托咪定/丙泊酚(DP)组和氯胺酮/丙泊酚(KP)组。 DP患者在15分钟内接受静脉注射右美托咪定1μg/ kg的负荷剂量,然后维持0.5μg/ kg / h的剂量。 KP组患者在15分钟内接受静脉内氯胺酮1 mg / kg的负荷剂量,然后维持0.5 mg / kg / h。异丙酚2 mg / kg,阿曲库铵0.5 mg / kg诱导麻醉以促进气管插管。丙泊酚输注5 mg / kg / h维持麻醉,如有需要,可间歇性静脉注射丙泊酚大剂量(0.5 mg / kg)。在装载研究药物之前(基线)记录MAP和HR,在整个过程中开始装载后以及插管后每5分钟记录一次MAP和HR,然后在术后1小时每15分钟记录一次。记录丙泊酚的总消耗量,恢复时间,VAS和术后并发症(PONV,认知功能障碍和呼吸道并发症)。结果在整个手术过程中,两组的术中HR和MAP差异有统计学意义,而DP组则较低(p <0.01或<0.001)。在手术后期间,DP组的HR和MAP显着降低。 DP组的异丙酚消耗量与两组相比相当(268.0±122.3 mg),而KP组则为(304.7±142.0 mg)。 DP组(5.7±1.7 min)的术后恢复时间明显少于(22.2±8.2 min)KP组(p <0.01)。两组的VAS相当。 PONV占KP组的46.67%,而DP组则不存在。术后认知障碍显示两组之间的统计学差异有统计学意义(p <0.001),而DP组无病例报告。两组均无呼吸并发症。结论与氯胺酮-异丙酚联合用药时,右美托咪定-丙泊酚联合用药(TIVA)在术中和术后具有较好的血流动力学稳定性,PONV少,术后认知功能障碍少,恢复时间短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号